Stephen Glover

Mr. Stephen C.
Glover is a Chairman, President & Chief Executive Officer at ZyVersa Therapeutics Operating, Inc., a Chairman, President & Chief Executive Officer at ZyVersa Therapeutics, Inc. and a Managing Principal at Asclepius Life Sciences Fund LP.
He is on the Board of Directors at Oncolytics Biotech, Inc., Asclepius Life Sciences Fund LP, Biogene Therapeutics, Inc., Inflamacore LLC, Two B Pharma and Wallace H.
Coulter Foundation.
Mr. Glover was previously employed as a Chairman by Ambrx Biopharma Cayman, Inc., a Chairman by Ambrx, Inc., a Chairman by PDS Biotechnology Corp., a Chairman by PDS Operating Corp., a Chief Business Officer by Coherus BioSciences, Inc., a President by Insmed Therapeutic Proteins, a Chief Business Officer & Executive Vice President by Insmed, Inc., a Senior Vice President-Brand Operations by Andrx Corp., a Principal by Amgen, Inc., a Senior Vice President & General Manager by Andrx Laboratories, Inc., a Principal by Hoffmann-La Roche, Inc., a Chief Business Officer by InteKrin Therapeutics, Inc., a Principal by IQVIA, Inc., and a Senior Vice President & General Manager by Watson Therapeutics, Inc. He also served on the board at Auriga Laboratories, Inc. and INCON Co., Ltd. He received his undergraduate degree from Illinois State University and an undergraduate degree from Illinois State University.